Market Opens

Vlad Tasevski, Chief Innovation Officer, Purpose Investments (“Purpose” or the “Company”) and his team, joined Graham MacKenzie, Managing Director, Exchange Traded Products, Toronto Stock Exchange (TSX), to open the market to celebrate the Company's new listing of Purpose Solana ETF (TSX: SOLL, SOLL.B & SOLL.U). Purpose Solana ETF unlocks direct exposure to a high-speed, low-cost blockchain known for its lightning-fast transactions, developer momentum, and real-world potential and is designed to provide investors with in-house staking rewards. The Purpose Solana ETF seeks to invest substantially all of its assets in long-term holdings of Solana and to provide holders of ETF Units with the opportunity for long-term capital appreciation. Purpose Investments is an asset management company with over $23 billion in assets under management, focused on client-centric innovation across ETFs and investment funds. The firm, which is known for launching the world’s first spot Bitcoin ETF, is a division of Purpose Unlimited, an independent financial technology company led by entrepreneur Som Seif.

Justin Flowerday, Managing Director, Head of Public Equities, TD Asset Management Inc., joined Graham MacKenzie, Managing Director, Exchange Traded Products, Toronto Stock Exchange (TSX), to open the market to celebrate the launch of the TD All-Equity ETF Portfolio (TSX: TEQT). TEQT is an all-equity ETF Portfolio solution that helps investors gain exposure to stocks in developed markets around the world in a low-cost and efficient way. The suite of all-in-one ETF Portfolios at TDAM provides investors a simple and efficient way to invest in a diversified portfolio with the stock / bond mix of their choice in a single product. TD Asset Management Inc. (TDAM) is a leading asset manager in Canada with an expanding global presence. We offer an extensive history of innovative solutions designed to provide better risk-adjusted returns with a long track record in integrating public and private market capabilities.

Pascal St-Jean, President and Chief Executive Officer, 3iQ (Company), and his team joined Graham MacKenzie, Managing Director, Exchange Traded Products, Toronto Stock Exchange (TSX), to close the market to celebrate the Company’s new listing of 3iQ Solana Staking ETF (TSX: SOLQ). 3iQ, founded in 2012, is one of the world's leading alternative digital asset managers, driving innovation with institutional-grade solutions that bring digital assets closer to mainstream and institutional investors. Building on its track record of industry firsts, including the launch of the 3iQ Bitcoin Fund (TSX: QBTC/QBTC.U), has the 3iQ Bitcoin ETF (TSX: BTCQ/BTCQ.U), and North America's first Staked Etherium ETF (TSX:ETHQ/ETHQ.U), 3iQ is focused on expanding opportunities for investors to get diversified digital asset exposure. In addition to its pioneering ETF offerings, 3iQ also provides hedge-fund-style, risk-managed strategies for institutional investors. In 2024, Monex Group, a prominent Japanese financial institution, acquired a majority stake in 3iQ.

Raj Lala, President and Chief Executive Officer, Evolve ETFs (“Evolve” or the “Company”), and his team joined Graham MacKenzie, Managing Director, Exchange Traded Products, Toronto Stock Exchange (TSX), to open the market to celebrate the Company's new listing of Evolve Solana ETF (TSX: SOLA & SOLA.U). SOLA’s investment objective is to provide Unitholders with exposure to the daily price movements of the U.S. dollar price of Solana while experiencing minimal tracking error by utilizing the benefits of the creation and redemption processes offered by the exchange traded fund structure. With over $7 billion in assets under management, Evolve specializes in bringing innovative ETFs to Canadian investors. Evolve’s suite of ETFs provide investors with access to: (i) index-based income strategies; (ii) long term investment themes; and (iii) some of the world’s leading investment managers. Established by a team of industry veterans with a demonstrated ability to succeed, Evolve creates investment products that make a difference.